- Cash
Volume Analysis
SPOT Pivot Levels
| Type | Classic | Fibonacci |
|---|---|---|
| R1 | 138.77 | 138.62 |
| R2 | 142.17 | 139.98 |
| R3 | 144.51 | 142.17 |
| PP | 136.43 | 136.43 |
| S1 | 138.77 | 138.62 |
| S2 | 130.69 | 132.88 |
| S3 | 127.29 | 130.69 |
Ratios
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| ROCE | - | 10.78 | - | 14.18 | - |
| ROE | - | 10.05 | - | 12.32 | - |
| EPS | 2.74 | 5.27 | 2.98 | 7.07 | 4.28 |
Peer Comparison
| Scrip Name | Price | Daily change | M Cap | PE Ratio | 1 Year Return |
|---|
Corporate Action
- Announcements
- Board Meetings
- Dividends
- Bonus
- Splits
- Rights
- AGM/EGM
- Credit Rating
About Kilitch Drugs (India) Ltd
Kilitch Drugs (India) Limited (KDIL), incorporated in May, 1992 is the one of the leading and fastest growing pharmaceutical companies in the world, manufacturing, supplying and marketing broad range of pharmaceutical formulations in the various dosage forms like Solid, Liquid and Parental across the globe. Their extensive research efforts have led to development of comprehensive, diverse and high...
ISIN :INE729D01010
Registered Office
C-301/2 MIDC TTC Indl Area,Pawane Village
Contact number
+ 91-022-27670322/27680913/65144185
Registrars
MUFG Intime India Pvt Ltd
C-101 247 Park L B S Marg Vikhroli West Mumbai-400083
C-101 247 Park L B S Marg Vikhroli West Mumbai-400083
Contact number
+ 91-22-49186000
Management
Mukund P Mehta (Chairman)
Mukund P Mehta (Director)
Open IPO’s
FAQs
The share price of Kilitch Drugs (India) Ltd on the BSE is - as on -